Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
47.1 USD | -0.86% | -9.32% | +338.96% |
May. 08 | Wedbush Raises Janux Therapeutics' PT to $74 From $53, Keeps Outperform Rating | MT |
May. 08 | Janux Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+338.96% | 2.46B | |
+33.63% | 50.85B | |
-0.09% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+11.18% | 26.11B | |
-21.95% | 19.13B | |
+8.61% | 13.05B | |
+28.31% | 12.16B | |
+24.73% | 12.08B |
- Stock Market
- Equities
- JANX Stock
- News Janux Therapeutics, Inc.
- JonesTrading Starts Janux Therapeutics With Buy Rating, $70 Price Target